Concepedia

High‐dose vitamins E and C supplementation prevents ribavirin‐induced hemolytic anemia in patients with chronic hepatitis C

Yasunori Kawaguchi, Toshihiko Mizuta, Kazuhiro Takahashi, Shinji Iwane, Keisuke Ario, Hiroaki Kawasoe, Kazuhiro Hamaoka, Yuichiro Eguchi, Tsutomu Yasutake, Hironao Shigematsu,

Hepatology Research · 2007 · 11 citations · 18 references

DOI

Abstract

High-dose vitamins E and C supplementation prevented ribavirin-induced hemolytic anemia during combination therapy with ribavirin and IFN alfa-2b in patients with chronic hepatitis C.

References

18

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6K citations

, , +7

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

John G. McHutchison, Stuart C. Gordon, Eugene R. Schiff et al. · New England Journal of Medicine · 1998 · 3.5K citations · Full text

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C

Stephanos J. Hadziyannis · Annals of Internal Medicine · 2004 · 2.8K citations

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · The Lancet · 1998 · 2.3K citations

, , +9

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

Gary L. Davis, Rafael Esteban, Vinod K. Rustgi et al. · New England Journal of Medicine · 1998 · 1.3K citations · Full text